V Mitrovic

Summary

Affiliation: Bad Nauheim
Country: Germany

Publications

  1. doi request reprint Soluble guanylate cyclase modulators in heart failure
    Veselin Mitrovic
    Kerckhoff Klinik gGmbH, Benekestrasse 2 8, Bad Nauheim, Germany
    Curr Heart Fail Rep 8:38-44. 2011
  2. doi request reprint Role of guanylate cyclase modulators in decompensated heart failure
    Veselin Mitrovic
    Kerckhoff Clinic GmbH, Bad Nauheim, Germany
    Heart Fail Rev 14:309-19. 2009
  3. doi request reprint Effects of candesartan cilexetil "add-on" treatment in congestive heart failure outpatients in daily practice
    Veselin Mitrovic
    Department of Cardiology, Kerckhoff Klinik GmbH, Bad Nauheim, Germany
    Clin Res Cardiol 98:379-89. 2009
  4. ncbi request reprint Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis
    V Mitrovic
    Kerckhoff Klinik GmbH, Benekestr 2 8, 61231 Bad Nauheim, Germany
    Z Kardiol 94:336-42. 2005
  5. ncbi request reprint Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease
    V Mitrovic
    Max Planck Institute for Clinical and Physiological Research, Kerckhoff Klinik, Bad Nauheim, Germany
    Clin Cardiol 21:492-502. 1998
  6. ncbi request reprint [Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol]
    V Mitrovic
    Kerckhoff Klinik GmbH, Benekestr 2 8, D 61231 Bad Nauheim
    Z Kardiol 88:838-49. 1999
  7. ncbi request reprint Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists
    V Mitrovic
    Max Planck Institute for Physiological and Clinical Research, Kerckhoff Klinik GmbH, Bad Nauheim, Germany
    Herz 25:130-42. 2000
  8. pmc Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis
    M Weber
    Kerckhoff Heart Center, Department of Cardiology, Bad Nauheim, Germany
    Heart 92:1639-44. 2006
  9. ncbi request reprint Hemodynamic, antiischemic, and neurohumoral effects of tedisamil and atenolol in patients with coronary artery disease
    V Mitrovic
    Max Planck Institute for Physiology and Clinical Research, Kerckhoff Klinik, Bad Nauheim, Germany
    Cardiovasc Drugs Ther 14:511-21. 2000
  10. ncbi request reprint Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes
    M Weber
    Kerckhoff Heart Center, Department of Cardiology, Bad Nauheim, Germany
    Clin Res Cardiol 95:270-80. 2006

Detail Information

Publications16

  1. doi request reprint Soluble guanylate cyclase modulators in heart failure
    Veselin Mitrovic
    Kerckhoff Klinik gGmbH, Benekestrasse 2 8, Bad Nauheim, Germany
    Curr Heart Fail Rep 8:38-44. 2011
    ..The sGC modulators play an important role in patients with heart failure and pulmonary hypertension...
  2. doi request reprint Role of guanylate cyclase modulators in decompensated heart failure
    Veselin Mitrovic
    Kerckhoff Clinic GmbH, Bad Nauheim, Germany
    Heart Fail Rev 14:309-19. 2009
    ..Preliminary studies of cinaciguat in patients with acute decompensated heart failure show substantial improvements in haemodynamics and symptoms, whilst maintaining renal function...
  3. doi request reprint Effects of candesartan cilexetil "add-on" treatment in congestive heart failure outpatients in daily practice
    Veselin Mitrovic
    Department of Cardiology, Kerckhoff Klinik GmbH, Bad Nauheim, Germany
    Clin Res Cardiol 98:379-89. 2009
    ..In the present study, we investigated the efficacy and safety of candesartan cilexetil (candesartan) as "add-on" treatment in congestive heart failure (CHF) in daily practice...
  4. ncbi request reprint Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis
    V Mitrovic
    Kerckhoff Klinik GmbH, Benekestr 2 8, 61231 Bad Nauheim, Germany
    Z Kardiol 94:336-42. 2005
    ..The aim of this study was to investigate the effect of a therapy with the angiotensin-converting enzyme (ACE) inhibitor ramipril on hs-CRP plasma concentrations in patients with atherosclerosis...
  5. ncbi request reprint Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease
    V Mitrovic
    Max Planck Institute for Clinical and Physiological Research, Kerckhoff Klinik, Bad Nauheim, Germany
    Clin Cardiol 21:492-502. 1998
    ..Tedisamil is a new bradycardic agent proven to exert anti-ischemic and antiarrhythmic effects by blockade of the different cardiac and vascular K+ currents...
  6. ncbi request reprint [Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol]
    V Mitrovic
    Kerckhoff Klinik GmbH, Benekestr 2 8, D 61231 Bad Nauheim
    Z Kardiol 88:838-49. 1999
    ....
  7. ncbi request reprint Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists
    V Mitrovic
    Max Planck Institute for Physiological and Clinical Research, Kerckhoff Klinik GmbH, Bad Nauheim, Germany
    Herz 25:130-42. 2000
    ..Compared with gallopamil, both tedisamil and esmolol were superior in their effects on myocardial oxygen consumption and ST segment depression, whereas plasma lactate concentrations were more reduced by tedisamil and gallopamil...
  8. pmc Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis
    M Weber
    Kerckhoff Heart Center, Department of Cardiology, Bad Nauheim, Germany
    Heart 92:1639-44. 2006
    ..To evaluate the prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with aortic stenosis being treated conservatively or undergoing aortic valve replacement (AVR)...
  9. ncbi request reprint Hemodynamic, antiischemic, and neurohumoral effects of tedisamil and atenolol in patients with coronary artery disease
    V Mitrovic
    Max Planck Institute for Physiology and Clinical Research, Kerckhoff Klinik, Bad Nauheim, Germany
    Cardiovasc Drugs Ther 14:511-21. 2000
    ..i.d.) generated similar hemodynamic, neurohumoral and antiischemic effects. The antiischemic efficacy of tedisamil, as measured by ST segment depression and angina threshold, was comparable to that of atenolol...
  10. ncbi request reprint Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes
    M Weber
    Kerckhoff Heart Center, Department of Cardiology, Bad Nauheim, Germany
    Clin Res Cardiol 95:270-80. 2006
    ..However, little data are available on the time course of NT-proBNP levels in relation to onset of symptoms...
  11. ncbi request reprint Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure
    V Mitrovic
    Kerckhoff Klinik der Max Planck Gesellschaft, Bad Nauheim, Germany
    Am Heart J 145:E14. 2003
    ..This study evaluated the short-term and long-term effects of the angiotensin II type 1 receptor antagonist candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure (CHF)...
  12. ncbi request reprint [Effect of the imidazoline receptor agonist moxonidine on hemodynamics, coronary circulation, metabolic ischemia markers and the neurohumoral system in patients with essential hypertension. Effects of moxonidine on coronary circulation]
    V Mitrovic
    Kerckhoff Klinik GmbH Benekestr 2 8, 61231 Bad Nauheim, Germany
    Z Kardiol 90:953-63. 2001
    ..In conclusion, moxonidine produces clinically relevant sympathicolysis with beneficial effects on hemodynamics, coronary circulation and neurohumoral parameters...
  13. pmc Left ventricular adaptation after atrial septal defect closure assessed by increased concentrations of N-terminal pro-brain natriuretic peptide and cardiac magnetic resonance imaging in adult patients
    M Weber
    Department of Cardiology, Kerckhoff Heart Centre, Bad Nauheim, Germany
    Heart 92:671-5. 2006
    ..To determine in an observational study whether N-terminal pro-brain natriuretic peptide (NT-proBNP) is raised in patients with an atrial septal defect (ASD) and whether concentrations change after interventional closure...
  14. ncbi request reprint [Cardiopulmonary exercise capacity increases after interventional ASD-closure]
    M Weber
    Kerckhoff Klinik, Abteilung fur Kardiologie, Benekestrasse 2 8, 61231 Bad Nauheim, Germany
    Z Kardiol 93:209-15. 2004
    ..The aim of this study was to evaluate exercise capacity as achieved by ergospirometry in adult patients with an ASD at baseline and in the long-term following transcatheter closure...
  15. ncbi request reprint Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder
    M Burian
    Department of Clinical Pharmacology, University Clinic of Johann Wolfgang Goethe University, Frankfurt Main, Germany
    Int J Clin Pharmacol Ther 44:107-12. 2006
    ..The present study was undertaken to evaluate the safety and release of nickel after implantation of a nickel device (Amplatzer occluder) in patients with an atrial septal defect (ASD) receiving antiplatelet therapy...
  16. ncbi request reprint Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease
    J Fielitz
    Innere Medizin, Kardiologie, Charite, , Germany
    J Am Coll Cardiol 37:1443-9. 2001
    ..The increase in extracellular matrix already exists in patients with a normal LVEF, and it increases with functional impairment...